White Marsh, MARYLAND3 Active Studies

Ankylosing Spondylitis Clinical Trials in White Marsh, MARYLAND

Find 3 actively recruiting ankylosing spondylitis clinical trials in White Marsh, MARYLAND. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
646
Enrolling

Recruiting Ankylosing Spondylitis Studies in White Marsh

About Ankylosing Spondylitis Clinical Trials in White Marsh

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in White Marsh, MARYLAND. These studies are seeking a combined 646 participants. Research is being sponsored by Upstream Bio Inc., Connect Biopharm LLC, Octapharma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in White Marsh — FAQ

Are there ankylosing spondylitis clinical trials in White Marsh?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in White Marsh, MARYLAND. Browse the studies on this page to find one that fits.

How do I join a clinical trial in White Marsh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the White Marsh research site will contact you about next steps.

Are clinical trials in White Marsh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many White Marsh studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in White Marsh are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov